Abstract: Introduction: the main methods for diagnosing cardiac neoplasms, allowing to determine the localization, size, involvement of heart structures, to suggest the nature of the pathological process and to plan treatment tactics, are: echocardiography (EchoCG), contrast multispiral computed coronary angiography (MSCT CAG), magnetic resonance imaging (MRI) and positron emission computed tomography (PET CT). At the same time, any additional information about the pathological process can improve the quality of diagnosis and treatment. So, for example, selective coronary angiography (CAG), which in this case can be performed to clarify the coronary anatomy and exclude concomitant coronary atherosclerosis, in hands of attentive and experienced specialist of endovascular diagnostic and treatment methods can make a significant contribution to understanding the nature of blood supply of heart neoplasm, thereby bringing closer the formulation of the correct diagnosis and, ultimately, improving results of surgical treatment. Aim: was to study the nature of blood supply of heart myxoma based on results of a detailed analysis of data of selective coronary angiography in patients with this pathology. Material and methods: since 2005, 20 patients underwent surgery to remove heart myxoma. The average age of patients was 56,6 + 8,0 (43-74) years. According to data of ultrasound examination, sizes of myxomas ranged from 10 to 46 mm in width and from 15 to 71 mm in length (average size ? 25,6 ? 39,1 mm). In 2/3 of all cases (15 out of 20,75%), the fibrous part of the inter-atrial septum (fossa oval region) was the base of myxomas. In 8 of 20 (40%) cases, tumor prolapse into the left ventricle through structures of the mitral valve was noted in varying degrees. In order to exclude coronary pathology, CAG was performed in 14 cases, in the rest - MSCT CAG. Results: of 14 patients with myxoma who underwent selective coronary angiography, 12 (85,7%) patients had distinct angiographic signs of vascularization. In all 12 cases, the sinus branch participated in the blood supply of myxoma, begins from the right coronary artery (RCA) in 10 cases: in 7 case it begins from proximal segment of the RCA and, in 3 cases, from the posterior-lateral branch (PLB) of the RCA. In one case, the source of blood supply of neoplasm was the sinus branch extending from PLB of dominant (left type) circumflex artery of the left coronary artery (PLB CxA LCA). In one case, the blood supply to the neoplasm involved branches both from the RCA and CxA, mainly from the left atrial branch of CxA. Moreover, in all 12 cases, sinus branch formed two branches: branch of sinus node itself and left atrial branch. It was the left atrial branch that was the source of blood supply of myxoma. Analysis of angiograms in patients with myxoma of LA showed that left atrial branch in terminal section formed a pathological vascularization in the LA projection, accumulating contrast-agent in the capillary phase (MBG 3-4). In addition to newly formed vascularization, lacunae of irregular shape were distinguished, the size of which varied from 2 to 8 mm along the long axis. In 8 cases, hypervascular areas with areas of lacunar accumulation of contrast-agent showed signs of paradoxical mobility and accelerated onset of venous phase. In two cases, there were distinct angiographic signs of arteriovenous shunt. In 2 cases (when the size of the myxoma did not exceed 15-20 mm according to EchoCG and CT), angiographic signs allowing to determine the presence of LA myxoma were not so convincing: there was no lacunar accumulation of contrast-agent; small (up to 10 mm) hypervascular areas were noticed, the capillary network of which stood out against the general background of uniform contrasting impregnation and corresponded to MBG grade 1-2. Conclusion: according to our data, angiographic signs of vascularization of myxomas are detected in most cases with this pathology (85,7%). The source of blood supply, in the overwhelming majority of cases, is branch of coronary artery, which normally supplies the structure of the heart, on which the basement of the pathological neoplasm is located. The aforementioned angiographic signs characteristic of myxomas deserve the attention of specialists in the field of endovascular diagnosis and treatment and should be described in details in protocols of invasive coronary angiography. References 1. Петровский Б.В., Константинов Б.А., Нечаенко М.А. Первичные опухоли сердца. М.: Медицина, 1997; 152. Petrovskiy BV, Konstantinov BA, Nechaenko MA. Primary heart tumors. M.: Medicina, 1997 [In Russ]. 2. Balci AY, Sargin M, Akansel S, et al. The importance of mass diameter in decision-making for preoperative coronary angiography in myxoma patients. Interact Cardiovasc Thorac Surg. 2019; 28(1): 52-57. https://doi.org/10.1093/icvts/ivy217 3. Omar HR. The value of coronary angiography in the work-up of atrial myxomas. Herz. 2015; 40(3): 442-446. 4. Gupta PN, Sagar N, Ramachandran R, Rajeshekharan VR. How does knowledge of the blood supply to an intracardiac tumour help? BMJ Case Rep. 2019; 12(2): 225900. https://doi.org/10.1136/bcr-2018-225900 5. Marshall WHJr., Steiner RM, Wexler L. Tumor vascularity in left atrial myxoma demonstrated by selective coronary arteriography. Radiology. 1969; 93(4): 815-816. 6. Lee SY, Lee SH, Jung SM, et al. Value of Coronary Angiography in the Cardiac Myxoma. Clin Anat. 2020; 33(6): 833-838.
Abstract: Aim: was to assess the consistency of measurements of anatomic and functional parameters performed with EchoCG and MRI and to determine the possibility of MRI to visualize the coaptation of valve leaflets after reconstruction of the aortic valve (AV) using the Ozaki technique. Material and methods: the study included 124 patients who underwent MRI of the heart anc transthoracic EchoCG, 9,3±4,0 days after the Ozaki operation. With EchoCG and MRI, EDV and LV EF were calculated. Dopplerography determined the area of AV opening and the transaortal pressure gradient. At MRI, the area of AV opening was planetically measured, and the transoortal pressure gradient was calculated from results of phase contrast study To assess the consistency of measurement results, the Blend-Altman method was used. Results: mean values obtained with EchoCG and MRI were statistically significantly different (p<0,001) only when measuring LV EDV The greatest accordance between measurements of EchoCG and MRI was observed in the evaluation of the transaortal pressure gradient (0,04± Conclusions: differences in consistency in the assessment of the opening area of the AV and the transaortal pressure gradient in echocardiography and MRI are not clinically significant, indicating that these measurement methods can be used interchangeably after AV reconstruction using the Ozaki technique. Results of measurements of EDV size and LV EF in EchoCG and MRI are less consistent and not interchangeable, therefore, measurement results should be interpreted in the context of the specific method MRI should be a part of the diagnostic algorithm after Ozaki surgery, but its use in the early postoperative period may be limited to cases of poor quality or inconsistent Echocardiography References 1. Salem M. A.; Abd El-Razek M. A.; Bassiouny M. I. et al. Diagnostic Value of Cardiac MRI in Aortic Valve Stenosis in Comparison with Echocardiography. Med J Cairo Univ., 2016; 84 (2):271-278. 2. Sondergaard L., Hildebrandt P., Lindvig K., et al. Quantification by magnetic resonance velocity mapping. Am Heart J., 1993; 26(5):156-1164. 3. Bellenger N.G., Burgess M.I., Ray S.G. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionucleide ventriculography and cardiovascular magnetic resonance. Are they interchangeable?. Eur Heart J., 2000; 21:1387-1396. 4. Bellenger N.G., Francis J.M., Davies L.C. et al. Establishment and performance of a magnetic resonance cardiac function clinic. J Cardiovasc Magn Reson. 1999; 1(4):323-330. 5. Bernard Y, Meneveau N., Boucher S. et al. Lack of agreement between left ventricular volumes and ejection fraction determined by two-dimensional echocardiography and contrast cineangiography in postinfarction patients. Echocardiography. 2001;18:113-122. 6. Darasz K.H., Underwood S.R., Bayliss J. et al. Measurement of left ventricular volume after anterior myocardial infarction: comparison of magnetic resonance imaging, echocardiography, and radionuclide ventriculography. The Int J of Cardiovasc Imaging. 2002;18(2):135-142. 7. Gardner B., Bingham S., Allen M. et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings. The J of Cardiovasc ultrasound. 2009;7:38-44. 8. Li C., Lossnitzer D., Katus H.A. et al. Comparison of left ventricular volumes and ejection fraction by monoplane cineventriculography, unenhanced echocardiography and cardiac magnetic resonance imaging. Int J Cardiovasc Imaging. 2012; 28(5):1003-1010. 9. Malm S., Frigstad S., Sagberg E.; et al. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography a comparison with magnetic resonance imaging. J Am Coll Cardiol. 2004; 44(5):1030-1035. 10. Ozaki S. Pathophysiology of calcification of bioprosthetic heart valves: an experimental investigation. 11. Ozaki S., 12. Rossejkin E.V., Bazylev V.V., Batrakov P.A. i dr. Neposredstvennye rezul'taty protezirovanija stvorok aortal'nogo klapana autoperikardom po metodike Ozaki [Immediate results of aortic valve leaflets replacement with auto pericardium due to Ozaki technique]. Patobgija krovoobrashhenija i kardiohirurgija. 2016; 20(2):44-48 [ In Russ]. 13. Ozaki S., Kawase I., Yamashita H., et al. Aortic Valve Reconstruction Using Autologous Pericardium for Aortic Stenosis. Circ J. 2015; 79(7):1504-1510. 14. Izgi C. MRI evaluation of aortic stenosis: flow evaluation. https://www.escardio.org/Education/PracticeTools/ EACVI-toolboxes/Valvular-Imaging/Atlas-of-valvular-imaging/Aortic-stenosis/MRI-evaluation-of-aortic- stenosis-flow-evaluation 15. La Manna A., Sanfilippo A., Capodanno D. et al. Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Reson. 2011;13: 82-90. 16. Rajani R., Hancock J., Chambers J.B. The art of assessing aortic stenosis. Heart. 2012;98(4):14-22. 17. Oosterhof T, Mulder B.J.M., Vliegen H.W. et al. Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot. American Heart J. 2006;151:265-272. 18. Bazylev V.V., Paramonova T.I., Vdovkin A.V., Pal'kova V.A. Pri kakom razmere KDO u bol'nyh s sistolicheskoj disfunkciej levogo zheludochka predpochtitel'no vypolnenie magnitno-rezonansnoj tomografii [What dimensions of EDV in patients with systolic dysfunction of the left ventricle is preferable to perform MRI?.]. Diagnosticheskaja i intervencionnaja radiologija. 2017;11(2):30-37 [In Russ]. 19. Bazylev V.V., Paramonova T.I., Vdovkin A.V., Karpuhin V.G., Pal'kova V.A. Soglasovannost' JehoKG i MRT v ocenke mitral'noj regurgitacii i KDO u bol'nyh s dilataciej levogo zheludochka [Accordance of MRI and EchoCG in estimation of mitral regurgitation and EDV in patients with left ventricle dilatation]. Luchevaja diagnostika i terapija. 2017;1 (8): 64-68 [ In Russ].
